New Lung Cancer Clinical Practice Guidelines released in China

"Primary Lung Cancer Diagnosis and Treatment Practice Guidelines-2015" was published in Jan. 28, 2015 on Chinese Journal of Oncology. This is the most updated lung cancer clinical practice guideline to date in China. The last one was issued in 2011.

These guidelines were written by Expert Committee of National Health and Family Planning Commission (NHFPC).  

Consulting experts
Dr. Sun Yan Academician of Chinese Science Academy	Cancer Hospital, Chinese Medical Science Academy, Beijing
Dr. Hao Jie Academician of Chinese Engineering Academy	Cancer Hospital, Chinese Medical Science Academy, Beijing
Chairman
Dr. Zhi Xiuyi Professor	Xuanwu Hospital, Capital Medical University, Beijing
Dr. Shi Yuankai PhD Professor	Cancer Hospital, Chinese Medical Science Academy, Beijing
Dr. Yu Jinming Academician of Chinese Engineering Academy	Cancer Hospital of Shandong Province, Jinan, Shandong Province

According to Prof. Zhi Xiuyi, the highlights of the new Principles are:

• Multiple specialties integrated into the lung cancer patient care;
• More comprehensive coverage not only includes minimal wound thoracic surgery, target chemotherapy, and precision radiotherapy, but also lung cancer genetic subtypes, blood tumor markers, smoking cessation and screening;  
• Recommendation for low dosage spiral CT used for screening in high risk people;
• Q & A section based on evidence-medicine.   

These guidelines are largely in accordance with American National Comprehensive Cancer Network (NCCN) guidelines on lung cancer management, with certain adaptations to Chinese lung cancer patients and status quo of China.   

References:

1. "China Primary Lung Cancer Diagnosis and Treatment Practice Guidelines-2015" Chin J of Oncol. 2015,37(01): 67-1. DOI: 10.3760/cma.j.issn.0253-3766.2015.01.014

2. "'China Primary Lung Cancer Diagnosis and Treatment Practice Guidelines-2015' and experts commentary" Feb. 28, Oncology frontier, Imedtimes.com